pH monitoring in the esophago-gastric junction and stomach beore and after esophageal variceal treatment

pH monitoring in the esophago-gastric junction and stomach beore and after esophageal variceal treatment - pH monitoring beore and after esophageal variceal treatment

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008337

Enrollment

Registered

2012-07-05

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1) Patients between 20 and 80 years old. 2) Patients have esophageal varices which could be treated by EVL therapy. 3) Patients with liver cirrhosis are Child-Pugh Classification (A or B).

Interventions

Esophageal variceal ligation (EVL)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who had F2 esophageal varices or larger and can receive EVL treatment.

Exclusion criteria

Exclusion criteria: Ongoing pharmacological acid supressive therapy; Drinking alcohol within 3 months before the start of the study; Child-Pugh score Hepatocellular carcinoma (HCC); Portal thrombosis.

Design outcomes

Primary

Measure	Time frame
Comparing of 24 hours under pH 4 holding time (%) between beore and after EVL therapy in the esophago-gastric junction	—

Countries

Japan

Contacts

Public ContactHisashi Hidaka

Kitasato University East Hospital Department of Gastroenterology, Internal Medicine

hisashi7@kitasato-u.ac.jp+81-42-748-9111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026